Latov, N., Brannagan, T. H., Sander, H. W., & Gondim, F. de A. A. (2024). Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials. Arquivos de Neuro-Psiquiatria, 82(06), 001–007. CLOCKSS. https://doi.org/10.1055/s-0043-1777728

Miranda, C., & Brannagan, T. H. (2023). Acute/chronic inflammatory polyradiculoneuropathy. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders, 619–633. https://doi.org/10.1016/b978-0-323-98818-6.00026-1

Cook, M., Pasnoor, M., Ajroud‐Driss, S., Brannagan, T. H., Dimachkie, M. M., & Allen, J. A. (2022). CIDP prognosis in patients with IVIG treatment‐related fluctuations. Muscle & Nerve, 67(1), 69–73. Portico. https://doi.org/10.1002/mus.27746

Pullman, M. Y., Lewis, S. K., Brannagan, T. H., & Saunders-Pullman, R. (2021). Sustained Remission of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Celiac Disease After Immunotherapy and Gluten-Free Diet. Journal of Clinical Neuromuscular Disease, 23(1), 55–56. https://doi.org/10.1097/cnd.0000000000000348

Allen, J. A., Pasnoor, M., Dimachkie, M. M., Ajroud-Driss, S., Brannagan, T. H., Cook, A. A., Walton, T., Fiecas, M. B., Kissel, J. T., Merkies, I., Gorson, K. C., & Lewis, R. A. (2021). Quantifying Treatment-Related Fluctuations in CIDP. Neurology, 96(14). https://doi.org/10.1212/wnl.0000000000011703